PYXS – pyxis oncology, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

PYXS

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

1/17

01:11 am

pyxs

Pyxis Oncology (NASDAQ:PYXS) was upgraded by analysts at Wall Street Zen

Low Report

Pyxis Oncology (NASDAQ:PYXS) was upgraded by analysts at Wall Street Zen

Report

12/20

01:30 am

pyxs

Pyxis Oncology (NASDAQ:PYXS) was downgraded by analysts at Wall Street Z

Medium Report

Pyxis Oncology (NASDAQ:PYXS) was downgraded by analysts at Wall Street Z

Report

12/19

07:02 am

pyxs

Pyxis Oncology (NASDAQ:PYXS) had its "buy" rating reaffirmed by analysts at HC Wainwright.

High Report

Pyxis Oncology (NASDAQ:PYXS) had its "buy" rating reaffirmed by analysts at HC Wainwright.

Report

12/18

06:02 pm

pyxs

Pyxis Oncology (NASDAQ:PYXS) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.

High Report

Pyxis Oncology (NASDAQ:PYXS) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.

Report

11/24

08:05 am

pyxs

Pyxis Oncology (NASDAQ:PYXS) had its "overweight" rating reaffirmed by analysts at Stephens.

Medium Report

Pyxis Oncology (NASDAQ:PYXS) had its "overweight" rating reaffirmed by analysts at Stephens.

Report

11/6

06:56 am

pyxs

Pyxis Oncology (NASDAQ:PYXS) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.

Low Report

Pyxis Oncology (NASDAQ:PYXS) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.

Report

11/4

08:05 am

pyxs

Pyxis Oncology (NASDAQ:PYXS) was given a new $7.00 price target on by analysts at Guggenheim.

Low Report

Pyxis Oncology (NASDAQ:PYXS) was given a new $7.00 price target on by analysts at Guggenheim.

Report

11/3

04:05 pm

pyxs

Pyxis Oncology to Participate in Upcoming Investor Conferences

Low Report

Pyxis Oncology to Participate in Upcoming Investor Conferences

Report

11/3

10:59 am

pyxs

Pyxis Oncology (NASDAQ:PYXS) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $9.00 price target on the stock.

Medium Report

Pyxis Oncology (NASDAQ:PYXS) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $9.00 price target on the stock.

Report

11/3

07:00 am

pyxs

Pyxis Oncology Provides Business Update and Reports Third Quarter 2025 Financial Results

Medium Report

Pyxis Oncology Provides Business Update and Reports Third Quarter 2025 Financial Results

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.